Skip to main content
HR 5715 115th Congress House Health Administrative law and regulatory procedures Department of Health and Human Services Drug trafficking and controlled substances Drug, alcohol, tobacco use Fraud offenses and financial crimes Government information and archives Health care costs and insurance Health information and medical records Medicare Prescription drugs Public contracts and procurement Right of privacy

Strengthening Partnerships to Prevent Opioid Abuse Act

Introduced: May 9, 2018 See on congress.gov
 Everywhere this bill has been 6 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jun 12, 2018
Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 115-737, Part I.
May 23, 2018
Referred to the Subcommittee on Health.
May 17, 2018
Ordered to be Reported (Amended) by Voice Vote.
May 17, 2018
Committee Consideration and Mark-up Session Held.
May 9, 2018
Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
May 9, 2018
Introduced in House
 Plain-English summary Congressional Research Service

Strengthening Partnerships to Prevent Opioid Abuse Act

This bill requires the Centers for Medicare & Medicaid Services (CMS) to establish a secure online portal to allow: (1) data sharing among the CMS, Medicare prescription drug benefit plans, and Medicare Advantage (MA) plans; and (2) referrals by such plans of substantiated fraud, waste, or abuse in order to initiate or assist investigations by contracted entities under the Medicare Integrity Program. The CMS must disseminate and report certain collected information to such plans, including information regarding providers that were referred through the portal and trends in identifying suspicious activity.

Additionally, for plan years beginning on or after January 1, 2021, MA organizations must submit information to the CMS regarding investigations or other actions taken by MA plans against providers that prescribe high volumes of opioids (as determined by the CMS).

What's happening now June 12, 2018

Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 115-737, Part I.

 Committees of jurisdiction 3